Browse the evidence

Therapeutic doses of metformin (up to 2g/day) increase AMP-activated protein kinase (AMPK) activity in skeletal muscle of subjects with type 2 diabetes, leading to increased glucose disposal and glycogen storage.

For individuals with type 2 diabetes, metformin therapy (titrated up to 2g/day) activates AMPK in skeletal muscle, which improves glucose disposal and increases muscle glycogen storage. This mechanism complements its known effect of reducing liver glucose production. Consistent daily use as prescribed is key to maintaining these metabolic benefits.

Increased rates of free fatty acid (FFA) and lipid oxidation contribute to impaired suppression of hepatic glucose production (HGP) and diminished stimulation of glucose oxidation by insulin in NIDDM patients.

In NIDDM, high fat oxidation interferes with insulin's ability to suppress liver glucose output and promote glucose use. This suggests that strategies lowering lipid oxidation might improve insulin sensitivity.

Extended duration of rotating night shift work (defined as ≥3 nights/month) is associated with a modestly increased risk of developing type 2 diabetes in women, independent of lifestyle factors.

If you work rotating night shifts, your risk for type 2 diabetes is higher than day workers, even if you maintain a healthy weight. This is due to biological disruption of your body's internal clock, not just lifestyle choices. You should prioritize regular medical screening for blood sugar levels and discuss specific circadian health strategies with your healthcare provider, as standard lifestyle advice may need to be adapted for shift work.

Young women convert dietary alpha-linolenic acid (ALNA) to docosahexaenoic acid (DHA) at a rate (approx. 9%) significantly higher than previously reported for men (0-4%), likely due to estrogen-mediated upregulation of desaturation and elongation pathways.

If you are a woman, your body is biologically better equipped than a man's to turn plant-based omega-3s (alpha-linolenic acid) into DHA, a critical fat for brain and eye health. This is likely driven by estrogen. While you still benefit from direct DHA sources, you have a metabolic head start in converting flax, chia, or walnuts into usable DHA compared to men.

The AGEs/RAGE axis contributes to pancreatic beta cell toxicity and apoptosis via oxidative stress and islet amyloid polypeptide (IAPP) aggregation.

Preserving beta cell function is crucial; strategies that reduce AGEs and oxidative stress may help protect pancreatic beta cells.

Mitochondrial dysfunction in skeletal muscle is a consequence, not a cause, of insulin resistance and diabetes, driven by hyperglycemia- and hyperlipidemia-induced oxidative stress (ROS).

Mitochondrial damage in muscle is likely a result of long-term exposure to high blood sugar and fat, not the initial cause of your metabolic issues. Focusing on lowering blood glucose and improving lipid metabolism through diet and activity addresses the root cause of this damage, rather than just trying to 'boost' mitochondria with supplements.

Sustained hyperinsulinemia (elevated basal insulin levels) directly causes or sustains insulin resistance through homologous desensitization mechanisms, including receptor downregulation and post-receptor signaling defects.

High levels of insulin in your blood over time can make your body ignore insulin, leading to higher blood sugar. This happens whether the high insulin comes from your own body (due to obesity or genetics) or from external sources. Managing insulin levels, not just glucose, is key to improving sensitivity.

Pulsatile or intermittent administration of insulin minimizes desensitization and improves glucose utilization compared to continuous insulin exposure.

If you use insulin, mimicking your body's natural pulse-like release (rather than a constant drip) might work better with less insulin. This suggests that advanced delivery methods or timing strategies could improve effectiveness.

Biological adaptive mechanisms resist weight loss, making long-term maintenance of weight loss difficult without continuous intervention.

Expect your body to fight back after weight loss. This is a biological adaptation, not a personal failure. You will likely need to maintain a slightly higher activity level or lower intake than before to keep the weight off.

Metformin use is associated with a reduced incidence of hepatocellular carcinoma in patients with type 2 diabetes, whereas sulfonylurea or insulin use may increase risk.

If you have type 2 diabetes, talk to your doctor about whether metformin is the right choice for you. Research suggests that metformin may lower your risk of liver cancer compared to other diabetes medications like insulin or sulfonylureas.

Statin use is associated with a reduced incidence of hepatocellular carcinoma in patients with NAFLD.

If you have fatty liver disease, ask your doctor if a statin is appropriate for you. Studies suggest that statins may lower your risk of liver cancer in addition to helping with cholesterol and cardiovascular health.

Dietary palmitic acid intake does not significantly increase tissue palmitic acid levels because endogenous de novo lipogenesis (DNL) compensates by reducing synthesis, maintaining homeostasis under normal conditions.

If you are metabolically healthy, eating palmitic acid (found in palm oil, meat, dairy) does not automatically raise your body's palmitic acid levels. Your body compensates by making less internally. However, this balance breaks down if you have obesity, insulin resistance, or eat too many sugars, which force your body to overproduce fat.

In humans, endogenous leptin does not prevent obesity because obese individuals develop resistance to its effects, primarily due to impaired blood-brain barrier transport and intracellular signaling inhibition.

Your body's natural weight-control hormone (leptin) is present in high amounts but isn't working effectively due to resistance. This is a common physiological state in obesity, not a personal failure. While leptin itself isn't a magic bullet for weight loss in this state, understanding this resistance highlights why simple caloric restriction often triggers strong hunger signals (as leptin drops), making long-term management challenging without addressing the underlying energy balance.

Leptin functions primarily as a starvation signal to conserve energy during caloric deficit, rather than as a long-term regulator of body weight in humans.

When you lose weight, your leptin levels drop faster than your fat mass, signaling 'starvation' to your brain. This triggers hunger and slows metabolism to protect your energy stores. This is a normal survival mechanism, not a failure. Recognizing this helps explain why weight loss can become difficult over time and why sustainable habits are key to managing these hormonal signals.

Obesity is associated with increased expression of PPAR-gamma2 mRNA in human adipose tissue, with levels and the PPAR-gamma2/PPAR-gamma1 ratio positively correlating with BMI.

This research highlights that obesity involves a molecular upregulation of PPAR-gamma2, a key driver of fat cell formation. This suggests that the body's molecular machinery actively promotes fat storage in obesity, potentially making weight management biologically challenging. Understanding this mechanism underscores why simple caloric restriction might trigger compensatory molecular responses (like the rebound in PPAR-gamma2 seen during weight maintenance).

During prolonged low-intensity exercise (4 hours at 30% VO2max), blood glucose levels fall because hepatic glucose output fails to keep pace with augmented glucose utilization by working muscles, leading to significant liver glycogen depletion.

If you exercise for long durations (over an hour) at a moderate pace, expect your blood sugar to drop as your body depletes liver glycogen. This is a normal metabolic shift, not a failure. Ensure you are well-fed beforehand, but be aware that your body will increasingly rely on fat and gluconeogenesis as glycogen runs low.

Prolonged exercise stimulates hepatic gluconeogenesis, with an increasing fraction of glucose output derived from blood-borne precursors like lactate, glycerol, and amino acids (especially alanine) as exercise continues.

Your liver makes new glucose from other substances (like amino acids and glycerol) during long exercise. This is a normal process that helps maintain blood sugar when glycogen runs low.

Consumption of theabrownin, a pigment in Pu-erh tea, lowers serum and hepatic cholesterol and triglycerides by suppressing bile salt hydrolase (BSH) activity in gut microbiota, which increases ileal conjugated bile acids and inhibits the intestinal FXR-FGF15 signaling pathway, thereby stimulating hepatic bile acid synthesis and excretion.

Drinking Pu-erh tea (specifically the fermented variety rich in theabrownin) can help lower cholesterol and triglycerides. This works not by suppressing appetite, but by changing gut bacteria to reduce bile acid breakdown, which signals the liver to burn more cholesterol. A typical effective dose in the study was roughly 300ml of strong Pu-erh tea twice daily for humans, or equivalent purified theabrownin supplementation.

Obesity development is driven by hypothalamic inflammation and insulin/leptin resistance, where peripheral saturated fatty acids cross the blood-brain barrier to trigger microglial activation and ER stress, impairing the ability of hypothalamic neurons to regulate appetite and energy expenditure.

If you are struggling with weight gain despite diet efforts, recognize that high-fat diets can biologically alter brain signaling (insulin/leptin resistance) to promote hunger. This is not a character flaw but a physiological response to specific dietary patterns.

Plasma levels of the adipokine omentin-1 are significantly decreased in obese and overweight individuals compared to lean individuals, and these levels are inversely correlated with BMI, waist circumference, and insulin resistance.

This research identifies omentin-1 as a biomarker that drops as you gain visceral fat and become insulin resistant. While there is no current clinical test for omentin-1, this finding reinforces that reducing visceral fat (through caloric deficit and exercise) is likely to restore healthy adipokine profiles, including omentin-1, which may improve insulin sensitivity.

In the absence of adipose tissue, the liver becomes the primary site of action for thiazolidinediones (TZDs) like rosiglitazone.

For patients with severe lipoatrophy, TZDs like rosiglitazone work by acting on the liver, not fat. If you lack fat tissue, the liver is the key to the drug's effectiveness. In normal individuals, the liver's role in this drug's action is minor compared to fat tissue.

Leptin decreases hypothalamic AMPK activity, whereas ghrelin increases it, indicating that these hormones regulate food intake by modulating AMPK.

Your body uses hormones like leptin (satiety) and ghrelin (hunger) to control the brain's energy sensor (AMPK). Leptin turns this sensor down to stop eating, while ghrelin turns it up to start eating. Understanding this balance helps explain why hormonal imbalances can disrupt hunger cues.

Females in the Asia-Pacific region generally exhibit a higher prevalence of Metabolic Syndrome compared to males, although this varies by specific study and setting.

Women in the Asia-Pacific region face a higher risk of Metabolic Syndrome than men in most studies. This highlights the importance of targeted screening and prevention strategies for women, particularly in urban settings.

Adipose tissue expansion is dependent on angiogenesis; therefore, inhibiting angiogenesis prevents or reverses obesity by causing adipocyte apoptosis and reducing fat mass.

Fat tissue needs blood vessels to grow. If you stop the growth of new blood vessels, you stop the expansion of fat tissue. This is why antiangiogenic drugs can shrink fat.